Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pasquale Vergara has a total of 668 co-authors. Here are the top co-authors by number of shared publications:

  • Paolo Della Bella

    Arrhythmia Unit and Electrophysiology Laboratories IRCCS San Raffaele Scientific Institute Milan Italy

    34 shared publications
  • Paolo Della Bella

    Arrhythmia Unit and EP laboratories, San Raffaele Hospital, Milan, Italy

    22 shared publications
  • Simone Gulletta

    Arrhythmia Unit and Electrophysiology Laboratories IRCCS San Raffaele Scientific Institute Milan Italy

    16 shared publications
  • Nicola Trevisi

    Arrhythmia Unit and Electrophisiology Laboratories San Raffaele Scientific Institute Milano Italy

    15 shared publications
  • Caterina Bisceglia

    Arrhythmia Unit and Electrophisiology Laboratories San Raffaele Scientific Institute Milano Italy

    13 shared publications
  • Francesca Baratto

    IRCCS San Raffaele Hosp, Dept Arrhythmol, Via Olgettina 60, Milan, Italy

    13 shared publications

Latest Publications

  • Open Access

    Physics-Driven Sonification for Improving Multisensory Needle Guidance in Percutaneous Epicardial Access

    by Veronica Ruozzi, Sasan Matinfar, Pasquale Vergara, Alessandro Albanesi, Serena Dell'AVersana, Stefano Carugo, Gianluigi Buccoliero, Nassir Navab, Alberto Redaelli, Emiliano Votta

    Percutaneous epicardial access (PEA), performed on a beating heart under fluoroscopy, enables arrhythmia treatment. However, advancing a needle toward the thin, moving pericardium remains highly challenging and risky. To address this challenge, we present a novel physics-driven sonification method for Extended Reality (XR)-based multisensory navigation to enhance user perception regarding critically sensitive needle landing phase in PEA. Dynamic cardiac anatomy from 4DCTA was reconstructed and registered to a real-world coordinate system. Real-time needle tracking provided data of the needle tip relative to moving cardiac structures, driving the audio-visual feedback module. The visual display presents navigational cues and dynamic cardiac structures, whereas the auditory display encodes physiological cardiac states into a rigorous mapping through a multilayered physical membrane. To prove this novel concept, a phantom study was conducted with twelve cardiologists performing needle insertions under visual-only and multisensory feedback. Results show that the proposed multisensory method improved the navigation safety (χ2 = 11.30, p < 0.01), reducing myocardial contact (3.64% vs. 7.27%) and increasing correct access (90.91% vs. 52.73%). Needle placement accuracy improved, with closer membrane proximity (Cliff’s δ = 0.19) and reduced variability (Fligner p < 0.05). Execution time remained comparable, but time–accuracy correlations differed significantly between modalities (Fisher’s p < 0.01). NASA-TLX showed lower cognitive load with multisensory guidance (t = −4.02, p < 0.01). In conclusion, the multisensory system is associated with improved spatiotemporal awareness and suggests potential benefits for surgical navigation, while indicating reduced cognitive load. These findings demonstrate the feasibility of physics-driven sonification for supporting user-centered interaction and motivate further validation in realistic and clinical environments.

  • Nationwide survey on the current clinical practice of the first atrial fibrillation episode

    by Pasquale Vergara, Federico Migliore, Martina Nesti, Carlo Pignalberi, Manuel Antonio Conti, Francesco Borrello, Amir Kol, Pietro Rossi, Pasquale Visconti, Benedetta Brescia, et al.

  • Optimising implantable loop recorder alerts with artificial intelligence: role of R-wave amplitude and workload reduction

    by Luigi Cocchiara, Benedetta Brescia, Procolo Marchese, Stefano Nardi, Gianmarco Arabia, Alfonsomaria Salucci, Francesca Gennaro, Giovanni Mazzotta, Lucio Addeo, Emiliano Calvi, et al.

    Background False-positive (FP) alerts from implantable loop recorders increase clinical workload and may delay appropriate intervention. AccuRhythm AI, a cloud-based filtering algorithm, is designed to reduce these alerts in Reveal LINQ and LINQ II devices. This study assessed the algorithm’s effect on FP and clinician burden reduction, with a focus on the influence of R-wave sensing amplitude. Methods This multicentre, retrospective study included 800 patients with either Reveal LINQ or LINQ II. We analysed automated artificial intelligence (AI) reports and compared FP rates and transmission burden before and after software-based AI activation in the subset of Reveal LINQ patients to assess patient-level changes. The relationship between R-wave amplitude and FP incidence was also evaluated. Results AI-based filtering, by AccuRhythm AI automatic analysis, reduced false pause alerts by 62% and false atrial fibrillation alerts by 33%, saving 210 clinician hours over 6 months. Patient level analysis, among 465 Reveal LINQ patients, showed FP+ patients (patients with ≥1 false-positive transmission) reduction from 55.5% to 15.1% post-AI (pConclusion Use of AccuRhythm AI was associated with a significant reduction in FPs and clinician workload while preserving diagnostic accuracy. R-wave amplitude remained a key factor influencing alert specificity, emphasising the continued importance of optimal device implantation and signal quality.


  • Open Access

    Genetic variants associated with ventricular arrhythmias during ajmaline test in Brugada syndrome

    by Charles Audiat, Luigi Pannone, Antonio Sorgente, Pasquale Vergara, Domenico Giovanni Della Rocca, Ivan Eltsov, Gudrun Pappaert, Ingrid Overeinder, Gezim Bala, Alexandre Almorad, et al.

    Graphical Abstract Pathogenic/Likely Pathogenic variants identified in SCN5A and associated with ajmaline-induced ventricular fibrillation following ACMG guidelines


  • Open Access

    A Hybrid Minimally Invasive Atrial Fibrillation Ablation Procedure Using Unilateral Thoracoscopy and Endocardial Pulsed Field Ablation: An Early Feasibility Study

    by Ivan Eltsov, Luigi Pannone, Domenico Giovanni Della Rocca, Massimiliano Marini, Giacomo Talevi, Andrea Maria Paparella, Pasquale Vergara, Erwin Ströker, Juan Sieira, Gian-Battista Chierchia, et al.

    (1) Objective: To examine the efficiency and efficacy of using endovascular mapping and pulsed field ablation in the setting of a hybrid video-assisted thoracoscopic atrial fibrillation (AF) ablation procedure. (2) Methods: Eleven consecutive patients underwent hybrid video-assisted thoracoscopic epicardial ablation and left atrial appendage exclusion followed by endocardial ablation using pulsed field ablation energy. The completeness of epicardial and endocardial lesion sets were assessed using 3D electro-anatomical mapping. (3) Results: Left atrial appendage (LAA) exclusion and durable pulmonary vein isolation (PVI) and posterior wall isolation (PWI) were achieved in all patients. The endovascular part of the necessary lesion set using PFA energy was successful in 100% of the patients. All patients remained in SR during the 12-month follow-up period. (4) Conclusions: Our study confirms the feasibility of using endovascular pulsed field ablation to complete previously performed epicardial lesion sets during the hybrid AF ablation procedures, without extending the procedure time or increasing the risk of complications.


  • In Vivo Mapping of Human Ventricular Fibrillation in Brugada Syndrome: The Role of Repolarization Heterogeneity

    by Luigi Pannone, Domenico Giovanni Della Rocca, Pasquale Vergara, Antonio Sorgente, Alvise Del Monte, Giampaolo Vetta, Maria Cespon Fernandez, Giacomo Talevi, Ivan Eltsov, Paul-Adrian Calburean, et al.

    BACKGROUND: Brugada syndrome (BrS) is associated with ventricular fibrillation (VF). Different VF mechanisms have been described, and repolarization gradients were associated with VF in a BrS model. The aim of this study is to map VF in BrS with ECG imaging. Furthermore, spatial correlation between sinus rhythm maps and VF maps was evaluated. METHODS: Inclusion criteria were (1) BrS diagnosis and (2) VF mapped with ECG imaging during right ventricle outflow tract ablation. VF mechanism was classified into (1) rotational, (2) focal, and (3) irregular. For comparison, 6 controls were enrolled. The following sinus rhythm maps were performed: activation, recovery time, and activation-recovery interval time. Spatial overlap between steep repolarization gradients (cliffs) at recovery time and activation-recovery interval time maps and initiating VF rotational activity was evaluated with photogrammetry. RESULTS: A total of 28 VF maps in 21 patients with BrS were analyzed. In the first ≈7 seconds of VF, rotational, focal, and irregular mechanisms were found. In 19 patients with BrS (90.5%) and none of the controls, a right ventricle outflow tract repolarization cliff only was found. In all these patients, the singularity point of the first initiating rotational VF activity spatially overlapped with the right ventricle outflow tract cliff. Abolition of right ventricle outflow tract repolarization cliffs was confirmed in all but 2 patients (94.3%). In one patient with recurrence, VF was mapped on the anterior right ventricle over a cliff that was not targeted at the first ablation procedure. CONCLUSIONS: In patients with BrS, repolarization heterogeneity has a critical role in VF. Repolarization cliffs might be a therapeutic target in VF ablation.


  • Open Access

    P49 THE IMPACT OF MITRAL VALVE SURGERY ON VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH BARLOW’S DISEASE: PRELIMINARY RESULTS OF A PROSPECTIVE STUDY

    by G Ascione, N Azzola Guicciardi, A Boccellino, E Lapenna, A Palmisano, P Della Bella, A Esposito, E Agricola, O Alfieri, A Castiglioni, et al.

    Barlow’s disease is associated with malignant ventricular arrhythmias (VA) and sudden cardiac death. No definitive data are available on baseline arrhythmic burden and evolution of VA in pts undergoing mitral surgery for concomitant severe mitral regurgitation (MR), therefore we started a prospective, single–center study with these two aims. Materials & From February 2021 to May 2022, 88 consecutive pts with severe MR and Barlow’s disease were admitted to our Institution for surgical treatment of MR and were prospectively enrolled in this study. All pts underwent 24–hour Holter monitoring before surgery. A subgroup of them (16 pts, 18.2%) also had either cardiac MRI or CT scan, to detect myocardial fibrosis. Sixty–three mitral repair pts completed 3 months echocardiographic and Holter follow–up. Significant arrhythmic burden was defined as >= 1% premature ventricular beats (PVB)/24 h or at least one episode of non sustained ventricular tachycardia (NSVT), ventricular tachycardia (VT) or ventricular fibrillation (VF). Preoperative, intra and postoperative variables were compared between arrhythmogenic (AR) and non–arrhythmogenic (NAR) pts. At baseline (88 patients): • 29 patients (33%) had significant arrhythmic burden (median 2000 PVB/24h) and 59 did not (67%, median 24 PVB/24h) • AR pts tended to be more often females with history of palpitations. Changes in VA were assessed in 63 mitral repair pts who completed 3 months follow–up. Among them, those with significant arrhythmic burden at baseline (20 pts) did not show significant VA at follow–up in 55 % of cases, while pts without relevant VA at baseline remained free from them in 81.4% of cases and worsened in 18.6% (8 pts). In our experience, 1/3 of Barlow’s pts with severe MR, referred for mitral surgery, showed a significant arrhythmic burden.These pts more frequently experienced palpitations and were affected by polymorphic PVB, but no other differences were found in clinical or echocardiographic characteristics (including MAD prevalence) between AR and NAR subjects. Almost half of pts with arrhythmic burden at baseline were free from significant VA after mitral repair. However, a minority (18.6%) of subjects without arrhythmic burden at baseline experienced a significant PVB burden at follow–up. Our prospective study will continue to enroll pts to investigate in a larger sample with longer follow–up the role of MV repair on VA.

  • Open Access

    Genetic testing in children with Brugada syndrome: results from a large prospective registry

    by Luigi Pannone, Antonio Bisignani, Randy Osei, Anaïs Gauthey, Antonio Sorgente, Pasquale Vergara, Cinzia Monaco, Domenico Giovanni Della Rocca, Alvise Del Monte, Antanas Strazdas, et al.

    Aims: A pathogenic/likely pathogenic (P/LP) variant in SCN5A is found in 20–25% of patients with Brugada syndrome (BrS). However, the diagnostic yield and prognosis of gene panel testing in paediatric BrS is unclear. The aim of this study is to define the diagnostic yield and outcomes of SCN5A gene testing with ACMG variant classification in paediatric BrS patients compared with adults. Methods and results: All consecutive patients diagnosed with BrS, between 1992 and 2022, were prospectively enrolled in the UZ Brussel BrS registry. Inclusion criteria were: (i) BrS diagnosis; (ii) genetic analysis performed with a large gene panel; and (iii) classification of gene variants following ACMG guidelines. Paediatric patients were defined as ≤16 years of age. The primary endpoint was ventricular arrhythmias (VAs). A total of 500 BrS patients were included, with 63 paediatric patients and 437 adult patients. Among children with BrS, 29 patients (46%) had a P/LP variant (P+) in SCN5A and no variants were found in 34 (54%) patients (P−). After a mean follow-up of 125.9 months, 8 children (12.7%) experienced a VA, treated with implanted cardioverter defibrillator shock. At survival analysis, P− paediatric patients had higher VA-free survival during the follow-up, compared with P+ paediatric patients. P+ status was an independent predictor of VA. There was no difference in VA-free survival between paediatric and adult BrS patients for both P− and P+. Conclusion: In a large BrS cohort, the diagnostic yield for P/LP variants in the paediatric population is 46%. P+ children with BrS have a worse arrhythmic prognosis.


  • Role of comorbidities on the mortality in patients with SARS-CoV-2 infection: an Italian cohort study

    by Pasquale Vergara, Luca Rossi, Andrea Biagi, Giulio Falasconi, Luigi Pannone, Alessia Zanni, Concetta Sticozzi, Greta Comastri, Stefano Gandolfi, Cosmo Godino, et al.

    BACKGROUND: Cardiovascular comorbidities are a common cause of death in COVID-19 and the aim of this study is to evaluate the effect of comorbidities on mortality in COVID-19 patients. METHODS: In this retrospective observational study we enrolled 1049 patients hospitalized with confirmed SARS-CoV-2 infection in a single Italian Center from 21 February to 20 March 2020 Evaluated risk factors (RFs) were: advanced age, gender, hypertension, diabetes, atrial fibrillation, hyperlipidemia, chronic kidney disease, thyroid disease, chronic obstruc-tive pulmonary disease, malignancy, stroke, cardiovascular disease, and peripheral vascular disease. Endpoint of the study was death from any cause. A multivariate logistic regression model was built using covariates that showed as statistically significant at univariate regression analysis. RESULTS: Median age at presentation was 71.1 years (IQR: 59.1-80.5); 244 (72.2%) were males. Primary outcome oc-curred in 338 patients (32.2%). In decedents, median survival from Hospitalization was 6 (IQR: 3-10) days. 264 dece-dents had 1 RF, 120 had 2 RFs and 39 had >3 RFs. At multivariate logistic regression model, variables associated with primary outcome were: age class (64-69 years) (OR 3.03, CI: 1.75-5.31, P<0.001), age class (70-88 years) (OR 10.08, CI: 6.67-15.72, P88 years) (OR 23.99, CI: 13.21-44.82, P<0.001), male gender (OR 1.88, CI: 1.36-2.62, P<0.001), diabetes (OR 1.56, CI: 1.07-2.26, P=0.02), stroke (OR 3.41, CI: 1.33-9.91, P=0.015). CONCLUSIONS: Age, male gender, presence of diabetes and stroke appeared as independent predictors of mortality in COVID-19 patients. A table for risk of 30 days-mortality in SARS-CoV-2 infection was built, based on odds ratios derived from multivariate regression analysis. (Cite this article as: Vergara P, Rossi L, Biagi A, Falasconi G, Pannone L, Zanni A, et al. Role of comorbidities on the mortal-ity in patients with SARS-CoV-2 infection: an Italian cohort study. Minerva Med 2023;114:185-90. DOI: 10.23736/S0026-4806.21.07187-1)


  • Open Access

    Editorial: Sport activity: From beneficial effects to cardiac disease

    by Davide Romagnolo, Andre D′Avila, Federico Migliore, Pasquale Vergara

    Editorial: Sport activity: From beneficial effects to cardiac disease